[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"article-anthropic-buys-coefficient-bio-400m-stock-deal-en":3,"tags-anthropic-buys-coefficient-bio-400m-stock-deal-en":30,"related-lang-anthropic-buys-coefficient-bio-400m-stock-deal-en":41,"related-posts-anthropic-buys-coefficient-bio-400m-stock-deal-en":45,"series-industry-382db6f3-575b-4a89-933b-e3435477dca6":82},{"id":4,"title":5,"content":6,"summary":7,"source":8,"source_url":9,"author":10,"image_url":11,"keywords":12,"language":18,"translated_content":10,"views":19,"is_premium":20,"created_at":21,"updated_at":21,"cover_image":11,"published_at":22,"rewrite_status":23,"rewrite_error":10,"rewritten_from_id":24,"slug":25,"category":26,"related_article_id":27,"status":28,"google_indexed_at":29,"x_posted_at":10,"tweet_text":10,"title_rewritten_at":10,"title_original":10,"key_takeaways":10,"topic_cluster_id":10,"embedding":10,"is_canonical_seed":20},"382db6f3-575b-4a89-933b-e3435477dca6","Anthropic Buys Coefficient Bio in $400M+ Stock Deal","\u003Cp>\u003Ca href=\"https:\u002F\u002Fwww.anthropic.com\" target=\"_blank\" rel=\"noopener\">Anthropic\u003C\u002Fa> has bought stealth startup \u003Ca href=\"https:\u002F\u002Fwww.coefficient.bio\" target=\"_blank\" rel=\"noopener\">Coefficient Bio\u003C\u002Fa> in a deal worth just over $400 million in stock, according to reporting from \u003Ca href=\"https:\u002F\u002Fwww.newcomer.co\" target=\"_blank\" rel=\"noopener\">Newcomer\u003C\u002Fa>. The company is folding the team into its Health Care Life Sciences group, which is led by Eric Kauderer-Abrams, and the move says a lot about where Anthropic thinks its next serious technical bet lives: science, not media.\u003C\u002Fp>\u003Cp>The startup had been around for only eight months, yet it was already pitching a very large ambition. Coefficient Bio was building AI models for biological research, with a stated goal of pushing toward artificial superintelligence for science. That is a bold claim for any lab, and a rare one for a company that was still operating in stealth.\u003C\u002Fp>\u003Cp>The deal also adds another data point to Anthropic’s acquisition strategy. The company has already bought \u003Ca href=\"https:\u002F\u002Fbun.sh\" target=\"_blank\" rel=\"noopener\">Bun\u003C\u002Fa> and \u003Ca href=\"https:\u002F\u002Fvercept.com\" target=\"_blank\" rel=\"noopener\">Vercept\u003C\u002Fa>, and this latest purchase leans much harder into applied research than consumer software. In other words, Anthropic is spending equity on talent and technical direction, not just code.\u003C\u002Fp>\u003Ch2>What Anthropic bought\u003C\u002Fh2>\u003Cp>Coefficient Bio was backed by \u003Ca href=\"https:\u002F\u002Fwww.dimension.capital\" target=\"_blank\" rel=\"noopener\">Dimension\u003C\u002Fa>, the venture firm founded by former \u003Ca href=\"https:\u002F\u002Fwww.luxcapital.com\" target=\"_blank\" rel=\"noopener\">Lux Capital\u003C\u002Fa> partners and Obvious Ventures alum Adam Goulburn. Dimension reportedly owned about half the company, which helps explain why the fund is now talking up a 38,513% IRR on the investment. That number is eye-popping, although it comes from a tiny, short-lived stake in a startup that sold early.\u003C\u002Fp>\n\u003Cfigure class=\"my-6\">\u003Cimg src=\"https:\u002F\u002Fxxdpdyhzhpamafnrdkyq.supabase.co\u002Fstorage\u002Fv1\u002Fobject\u002Fpublic\u002Fcovers\u002Finline-1775250231846-68ym.png\" alt=\"Anthropic Buys Coefficient Bio in $400M+ Stock Deal\" class=\"rounded-xl w-full\" loading=\"lazy\" \u002F>\u003C\u002Ffigure>\n\u003Cp>According to the reporting, Coefficient Bio was formally founded only eight months ago. That timeline matters because it shows how quickly the AI-for-science market is moving. A startup can now go from formation to acquisition in less than a year if it attracts the right technical team and lands in the right strategic bucket.\u003C\u002Fp>\u003Cul>\u003Cli>Deal value: just over $400 million in stock\u003C\u002Fli>\u003Cli>Startup age: about 8 months\u003C\u002Fli>\u003Cli>Backer: Dimension\u003C\u002Fli>\u003Cli>Ownership reported: about 50%\u003C\u002Fli>\u003Cli>Buyer: Anthropic\u003C\u002Fli>\u003C\u002Ful>\u003Cp>Anthropic did not comment on the deal, and neither did Dimension, according to the report. That silence is normal for M&A, but the structure of the purchase is still informative. Stock-heavy deals often tell you the buyer wants the people and the research direction more than immediate revenue.\u003C\u002Fp>\u003Cp>The team is joining Anthropic’s Health Care Life Sciences group, which suggests the company wants this work close to its frontier model efforts. If you think of Anthropic as a general-purpose model company, this acquisition says it also wants to be a serious player in scientific tooling for biology and medicine.\u003C\u002Fp>\u003Ch2>Why the quote matters\u003C\u002Fh2>\u003Cp>Coefficient Bio was not shy about its ambition. In January, co-founder Samuel Stanton posted a recruiting pitch on X that framed the company’s mission in unusually sweeping terms. It is one of those lines that sounds like startup hype at first, then gets more interesting once a large model company writes a nine-figure check.\u003C\u002Fp>\u003Cblockquote>“We’re ushering biopharma into the Intelligence Age. It will change everything about how the industry learns and makes decisions.” — Samuel Stanton\u003C\u002Fblockquote>\u003Cp>That quote matters because it shows the company was not trying to sell a narrow workflow tool. It was trying to reposition how drug discovery and biological research get done. Anthropic clearly saw enough signal in that thesis to buy the whole operation rather than compete with it from the outside.\u003C\u002Fp>\u003Cp>There is also a strategic contrast here that is hard to ignore. On the same day this story circulated, the market was also digesting OpenAI’s purchase of a talk show. Anthropic’s move is the quieter one, but it may be the more consequential one if you care about where foundation models meet real-world science.\u003C\u002Fp>\u003Cp>For readers tracking AI company strategy, this is the kind of acquisition that signals discipline. Anthropic is not trying to be everything to everyone. It is picking domains where model capability, proprietary data, and specialized research talent can reinforce each other.\u003C\u002Fp>\u003Ch2>How this compares with other AI deals\u003C\u002Fh2>\u003Cp>Compared with Anthropic’s earlier acquisitions, Coefficient Bio is a much more domain-specific bet. Bun is a developer tool company; Vercept is a product and interface play. Coefficient Bio is about scientific discovery, and that puts it closer to the core research stack than to app-layer growth.\u003C\u002Fp>\n\u003Cfigure class=\"my-6\">\u003Cimg src=\"https:\u002F\u002Fxxdpdyhzhpamafnrdkyq.supabase.co\u002Fstorage\u002Fv1\u002Fobject\u002Fpublic\u002Fcovers\u002Finline-1775250249745-l3oa.png\" alt=\"Anthropic Buys Coefficient Bio in $400M+ Stock Deal\" class=\"rounded-xl w-full\" loading=\"lazy\" \u002F>\u003C\u002Ffigure>\n\u003Cp>The numbers also compare differently. Many startup acquisitions in stealth happen at modest valuations, especially when the company has little time to build a product or customer base. A $400 million-plus stock deal for an eight-month-old company suggests either unusual technical depth, unusual investor conviction, or both.\u003C\u002Fp>\u003Cul>\u003Cli>\u003Ca href=\"https:\u002F\u002Fopenai.com\" target=\"_blank\" rel=\"noopener\">OpenAI\u003C\u002Fa> bought a talk show-oriented media asset, which points toward audience and distribution\u003C\u002Fli>\u003Cli>\u003Ca href=\"https:\u002F\u002Fwww.anthropic.com\" target=\"_blank\" rel=\"noopener\">Anthropic\u003C\u002Fa> bought a biology-focused startup, which points toward research and science\u003C\u002Fli>\u003Cli>\u003Ca href=\"https:\u002F\u002Fwww.bun.sh\" target=\"_blank\" rel=\"noopener\">Bun\u003C\u002Fa> brought developer tooling into Anthropic’s orbit\u003C\u002Fli>\u003Cli>\u003Ca href=\"https:\u002F\u002Fvercept.com\" target=\"_blank\" rel=\"noopener\">Vercept\u003C\u002Fa> added another product-oriented acquisition to the mix\u003C\u002Fli>\u003C\u002Ful>\u003Cp>There is a practical reason this matters to the broader AI market. Foundation model companies are under pressure to show where their models create durable value. Buying a science startup is one way to convert model capability into a focused business line, especially in a field where compute, data, and expert feedback all matter.\u003C\u002Fp>\u003Cp>It is also worth noting that biology is a hard domain for pure software companies to crack. The data is messy, the experiments are expensive, and the feedback loops are slow. If Anthropic can pair its models with a specialized team that already thinks in biological systems, it may get a better shot at building tools researchers actually trust.\u003C\u002Fp>\u003Ch2>What happens next\u003C\u002Fh2>\u003Cp>Anthropic now has a clearer signal about where it wants to place bets outside general chat and coding. If the company keeps buying small, high-talent teams in narrow technical fields, expect more acquisitions around science, research infrastructure, and enterprise workflows tied to expert knowledge.\u003C\u002Fp>\u003Cp>My take: this deal is a sign that the next phase of AI competition will be less about flashy product launches and more about who can own the most valuable specialized workflows. If Anthropic keeps treating biology like a first-class strategic area, the next question is whether it follows with partnerships, model releases, or another acquisition in adjacent scientific tooling.\u003C\u002Fp>\u003Cp>For now, the takeaway is simple. When a company spends more than $400 million in stock on an eight-month-old stealth lab, it is buying a thesis, a team, and a shot at owning a category before it gets crowded.\u003C\u002Fp>\u003Cp>The real test comes over the next 12 months: can Anthropic turn Coefficient Bio’s research ambition into tools that help scientists move faster than they can with general-purpose models alone?\u003C\u002Fp>","Anthropic bought stealth bio startup Coefficient Bio for over $400M in stock, folding its science AI team into health care life sciences.","www.newcomer.co","https:\u002F\u002Fwww.newcomer.co\u002Fp\u002Fanthropic-buys-stealth-dimension",null,"https:\u002F\u002Fxxdpdyhzhpamafnrdkyq.supabase.co\u002Fstorage\u002Fv1\u002Fobject\u002Fpublic\u002Fcovers\u002Finline-1775250231846-68ym.png",[13,14,15,16,17],"Anthropic","Coefficient Bio","AI for biology","health care life sciences","startup acquisition","en",1,false,"2026-04-03T21:03:37.69206+00:00","2026-04-03T21:03:37.573+00:00","done","3b3794b3-d8a9-41c8-b673-e21442247252","anthropic-buys-coefficient-bio-400m-stock-deal-en","industry","edf0759b-15cf-4dac-a709-53db732f4a62","published","2026-04-07T07:41:08.953+00:00",[31,33,35,37,39],{"name":14,"slug":32},"coefficient-bio",{"name":17,"slug":34},"startup-acquisition",{"name":13,"slug":36},"anthropic",{"name":16,"slug":38},"health-care-life-sciences",{"name":15,"slug":40},"ai-for-biology",{"id":27,"slug":42,"title":43,"language":44},"anthropic-buys-coefficient-bio-400m-stock-deal-zh","Anthropic 砸4億美元買生技新創","zh",[46,52,58,64,70,76],{"id":47,"slug":48,"title":49,"cover_image":50,"image_url":50,"created_at":51,"category":26},"cf1863f5-624d-4b5f-bc32-d469c2149866","why-ai-infrastructure-is-now-the-real-moat-en","Why AI infrastructure is now the real moat","https:\u002F\u002Fxxdpdyhzhpamafnrdkyq.supabase.co\u002Fstorage\u002Fv1\u002Fobject\u002Fpublic\u002Fcovers\u002Finline-1778875858866-4ikl.png","2026-05-15T20:10:38.090619+00:00",{"id":53,"slug":54,"title":55,"cover_image":56,"image_url":56,"created_at":57,"category":26},"6ff3920d-c8ea-4cf3-8543-9cf9efc3fe36","circles-agent-stack-targets-machine-speed-payments-en","Circle’s Agent Stack targets machine-speed payments","https:\u002F\u002Fxxdpdyhzhpamafnrdkyq.supabase.co\u002Fstorage\u002Fv1\u002Fobject\u002Fpublic\u002Fcovers\u002Finline-1778871659638-hur1.png","2026-05-15T19:00:44.756112+00:00",{"id":59,"slug":60,"title":61,"cover_image":62,"image_url":62,"created_at":63,"category":26},"1270e2f4-6f3b-4772-9075-87c54b07a8d1","iren-signs-nvidia-ai-infrastructure-pact-en","IREN signs Nvidia AI infrastructure pact","https:\u002F\u002Fxxdpdyhzhpamafnrdkyq.supabase.co\u002Fstorage\u002Fv1\u002Fobject\u002Fpublic\u002Fcovers\u002Finline-1778871059665-3vhi.png","2026-05-15T18:50:38.162691+00:00",{"id":65,"slug":66,"title":67,"cover_image":68,"image_url":68,"created_at":69,"category":26},"b308c85e-ee9c-4de6-b702-dfad6d8da36f","circle-agent-stack-ai-payments-en","Circle launches Agent Stack for AI payments","https:\u002F\u002Fxxdpdyhzhpamafnrdkyq.supabase.co\u002Fstorage\u002Fv1\u002Fobject\u002Fpublic\u002Fcovers\u002Finline-1778870450891-zv1j.png","2026-05-15T18:40:31.462625+00:00",{"id":71,"slug":72,"title":73,"cover_image":74,"image_url":74,"created_at":75,"category":26},"f7028083-46ba-493b-a3db-dd6616a8c21f","why-nebius-ai-pivot-is-more-real-than-hype-en","Why Nebius’s AI Pivot Is More Real Than Hype","https:\u002F\u002Fxxdpdyhzhpamafnrdkyq.supabase.co\u002Fstorage\u002Fv1\u002Fobject\u002Fpublic\u002Fcovers\u002Finline-1778823055711-tbfv.png","2026-05-15T05:30:26.829489+00:00",{"id":77,"slug":78,"title":79,"cover_image":80,"image_url":80,"created_at":81,"category":26},"b63692ed-db6a-4dbd-b771-e1babdc94af7","nvidia-backs-corning-factories-with-billions-en","Nvidia backs Corning factories with billions","https:\u002F\u002Fxxdpdyhzhpamafnrdkyq.supabase.co\u002Fstorage\u002Fv1\u002Fobject\u002Fpublic\u002Fcovers\u002Finline-1778822444685-tvx6.png","2026-05-15T05:20:28.914908+00:00",[83,88,93,98,103,108,113,118,123,128],{"id":84,"slug":85,"title":86,"created_at":87},"d35a1bd9-e709-412e-a2df-392df1dc572a","ai-impact-2026-developments-market-en","AI's Impact in 2026: Key Developments and Market Shifts","2026-03-25T16:20:33.205823+00:00",{"id":89,"slug":90,"title":91,"created_at":92},"5ed27921-5fd6-492e-8c59-78393bf37710","trumps-ai-legislative-framework-en","Trump's AI Legislative Framework: What's Inside?","2026-03-25T16:22:20.005325+00:00",{"id":94,"slug":95,"title":96,"created_at":97},"e454a642-f03c-4794-b185-5f651aebbaca","nvidia-gtc-2026-key-highlights-innovations-en","NVIDIA GTC 2026: Key Highlights and Innovations","2026-03-25T16:22:47.882615+00:00",{"id":99,"slug":100,"title":101,"created_at":102},"0ebb5b16-774a-4922-945d-5f2ce1df5a6d","claude-usage-diversifies-learning-curves-en","Claude Usage Diversifies, Learning Curves Emerge","2026-03-25T16:25:50.770376+00:00",{"id":104,"slug":105,"title":106,"created_at":107},"69934e86-2fc5-4280-8223-7b917a48ace8","openclaw-ai-commoditization-concerns-en","OpenClaw's Rise Raises Concerns of AI Model Commoditization","2026-03-25T16:26:30.582047+00:00",{"id":109,"slug":110,"title":111,"created_at":112},"b4b2575b-2ac8-46b2-b90e-ab1d7c060797","google-gemini-ai-rollout-2026-en","Google's Gemini AI Rollout Extended to 2026","2026-03-25T16:28:14.808842+00:00",{"id":114,"slug":115,"title":116,"created_at":117},"6e18bc65-42ae-4ad0-b564-67d7f66b979e","meta-llama4-fabricated-results-scandal-en","Meta's Llama 4 Scandal: Fabricated AI Test Results Unveiled","2026-03-25T16:29:15.482836+00:00",{"id":119,"slug":120,"title":121,"created_at":122},"bf888e9d-08be-4f47-996c-7b24b5ab3500","accenture-mistral-ai-deployment-en","Accenture and Mistral AI Team Up for AI Deployment","2026-03-25T16:31:01.894655+00:00",{"id":124,"slug":125,"title":126,"created_at":127},"5382b536-fad2-49c6-ac85-9eb2bae49f35","mistral-ai-high-stakes-2026-en","Mistral AI: Facing High Stakes in 2026","2026-03-25T16:31:39.941974+00:00",{"id":129,"slug":130,"title":131,"created_at":132},"9da3d2d6-b669-4971-ba1d-17fdb3548ed5","cursors-meteoric-rise-pressures-en","Cursor's Meteoric Rise Faces Industry Pressures","2026-03-25T16:32:21.899217+00:00"]